Newsletter | December 13, 2024

12.13.24 -- Setting The Standard In Cell And Gene Therapy

Maximizing CAR-T Cell Yields With Perfusion And Stirred-Tank Bioreactors

Gain insights into process intensification, DOE, and serum-free media while discovering how advanced perfusion and stirred-tank bioreactors boost CAR-T yields, streamline scale-up, and reduce costs.

 

Setting the Standard in Cell and Gene Therapy

Discover solutions for cell and gene therapies that focus on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.

 

Producing Therapeutic Cardiomyocytes From iPSC Stem Cells

Experts from Albumedix and Heartseed show how they navigated challenges on the path to commercialization and successfully advanced a promising cardiomyocyte therapy to clinical trials.

 

Assessing E&Ls From Single-Use Systems Used In ATMP Production

In this webinar, presenters explore the impact of E&Ls on CGT development, qualify single-use systems for ATMPs, leverage cell-painting assays, and see how Sartorius supports process qualification with data and software.

 

Showcasing A Scalable Downstream Platform For Multiple AAV Serotypes

Learn how to maximize AAV full capsid recovery from clarification to polishing, establish a scalable platform for various serotypes from process development to manufacturing, and utilize analytical tools to measure empty/full capsid ratios and AAV titers.

 

Leading Biopharma Increases the Efficiency of Aliquoting Process

To optimize the efficiency of CAR-T cell therapy media preparation, this leading biopharmaceutical company partnered with Sartorius. Explore their innovative solution and its impact on streamlining workflows and enhancing production.